Anjali Sharma

Anjali Sharma

Auto-generated profile, based on publicly available information

Anjali Sharma

Department of Pharmaceutical Chemistry, Delhi Institute of Pharmaceutical Sciences and Research, Sector-3, MB Road, Pushp Vihar, Delhi 110017, India

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
ASAnjali Sharma
Anjali Sharma
SWSharad Wakode
Sharad Wakode
FFFaizana Fayaz
Faizana Fayaz
SKShaik Khasimbi
Shaik Khasimbi
FPFaheem Hyder Pottoo
Faheem Hyder Pottoo
AKAvneet Kaur
Avneet Kaur
Piperazine scaffolds are a group of heterocyclic atoms having pharmacological values and showing significant results in pharmaceutical chemistry. Piperazine has a flexible core structure for the design and synthesis of new bioactive compounds. These flexible heterogenous compounds exhibit various biological roles, primarily anticancer, antioxidant, cognition enhancers, antimicrobial, antibacterial, antiviral, antifungal, antiinflammatory, anti-HIV-1 inhibitors, antidiabetic, antimalarial, antidepressant, antianxiety and anticonvulsant activities, etc. In the past few years, researchers focused on the therapeutic profile of piperazine synthons for different biological targets. The present review highlights the development in designing pharmacological activities of nitrogen-containing piperazine moiety as a therapeutic agent. The extensive popularity of piperazine as a drug of abuse and their vast heterogeneity research efforts over the last years motivated the new investigators to further explore this area.

26 October 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
BKBhumika Kumar
Bhumika Kumar
MPMukesh Pandey
Mukesh Pandey
FPFaheem Hyder Pottoo
Faheem Hyder Pottoo
FFFaizana Fayaz
Faizana Fayaz
ASAnjali Sharma
Anjali Sharma
PSP.K. Sahoo
P.K. Sahoo
Parkinson’s disease is one of the most severe progressive neurodegenerative disorders, having a mortifying effect on the health of millions of people around the globe. The neural cells producing dopamine in the substantia nigra of the brain die out. This leads to symptoms like hypokinesia, rigidity, bradykinesia, and rest tremor. Parkinsonism cannot be cured, but the symptoms can be reduced with the intervention of medicinal drugs, surgical treatments, and physical therapies. Delivering drugs to the brain for treating Parkinson’s disease is very challenging. The blood-brain barrier acts as a highly selective semi-permeable barrier, which refrains the drug from reaching the brain. Conventional drug delivery systems used for Parkinson’s disease do not readily cross the blood barrier and further lead to several side-effects. Recent advancements in drug delivery technologies have facilitated drug delivery to the brain without flooding the bloodstream and by directly targeting the neurons. In the era of Nanotherapeutics, liposomes are an efficient drug delivery option for brain targeting. Liposomes facilitate the passage of drugs across the blood-brain barrier, enhances the efficacy of the drugs, and minimize the side effects related to it. The review aims at providing a broad updated view of the liposomes, which can be used for targeting Parkinson’s disease.

18 December 2020 in Current Organic Chemistry
Verified
Journal Article
Closed access
PDF file
ASAnjali Sharma
Anjali Sharma
SWSharad Wakode
Sharad Wakode
SSSupriya Sharma
Supriya Sharma
FFFaizana Fayaz
Faizana Fayaz
FPFaheem Hyder Pottoo
Faheem Hyder Pottoo
Green chemistry plays an important role in the development of sustainable production systems which involves tremendous research efforts on the design of synthetic and analytical techniques through resource-efficient ways. The improvement in synthetic reaction performances encourages the modern society to minimize energy and reagent consumption and waste generation. Explosion of the chemicals are referred as extremely toxic substances and have been allied with major harmful health effects, though no cure has been established due to the lack of curative therapeutic approaches. In view of the facts, green chemistry strategies trigger a new hope in the synthesis of safer biologically active compounds to meet the demands of disease free environment. Here, we highlighted the development of various compounds and greener techniques such as ultrasoundassisted method, microwave-assisted method, green solvent reactions, solvent free reactions, biomolecules and nanoformulations as a new healthy approach.

1 April 2014 in Asian Pacific Journal of Health Sciences
Verified
Journal Article
Open access
DSDevkant Sharma
Devkant Sharma
ASAnjali Sharma
Anjali Sharma

1 October 2021 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
BKBhumika Kumar
Bhumika Kumar
MPMukesh Pandey
Mukesh Pandey
AMAshwini Kumar Mishra
Ashwini Kumar Mishra
ASAnjali Sharma
Anjali Sharma
FFFaizana Fayaz
Faizana Fayaz
FPFaheem Hyder Pottoo
Faheem Hyder Pottoo
Dementia is a diverse category of chronic and progressive disorder, which is commonly associated with a loss of memory, difficulty in judgment, impaired language, cognitive impairment, and various other symptoms that affect a person’s daily routine life and social life. Dementia affects about 50 million people around the globe. Dementia exists in varied forms and is associated with various neurodegenerative disorders. Alzheimer's disease is the most common form, which accords for about 60% of thecases. Abnormal agglomeration of proteins in the brain has been linked to the pathogenesis of dementia. Autophagy is a necessary protein clearance mechanism, which is dependent on lysosomes. It is a basic physiological process that performs the crucial function of maintaining protein homeostasis within the cells. The autophagic dysfunction in dementia further complicates the disease by hampering the degradation and removing abnormal pathogenic proteins. In order to understand autophagic dysfunction, it is essential to know the genetics of autophagy as well as the mutations This understanding at the genetic level helps definethe relationship between dementia and autophagic dysfunction for developing the potential remedies for the treatment of dementia.